John N. Weinstein

188.5k citations

322 papers · 34.9k indexed · 11 hit papers · h-index 85

Impact in

Cancer Research top 0.05%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
Molecular Biology top 0.05%
- Gene expression and cancer classification
- Bioinformatics and Genomic Networks
- RNA modifications and cancer
- RNA Research and Splicing

Papers in

Molecular Biology 213
- Gene expression and cancer classification 44
- Bioinformatics and Genomic Networks 33
- Lipid Membrane Structure and Behavior 24
- Epigenetics and DNA Methylation 21
- RNA modifications and cancer 20
Virology 14

Co-authors: Joseph A. Ludwig Gordon B. Mills Kenna Shaw Joshua M. Stuart Kyle Ellrott Chris Sander Ilya Shmulevich Brad Ozenberger
Journals: Molecular Cancer Therapeutics (19 papers)Cancer Research (17 papers)Science (13 papers)Bioinformatics (13 papers)Proceedings of the National Academy of Sciences (12 papers)
Partner nations: United States France Poland

In The Last Decade

John N. Weinstein

317 papers receiving 33.7k citations

Hit Papers

11 papers align trajectories log scale

Integrated Analysis of TP53 Gene and Pathway Alterations in The Cancer Genome Atlas 2019 · 421 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Cell Reports
2013 Nature Genetics
2005 Nature reviews. Cancer
2003 Genome biology
2001 Proceedings of the National Academy of Sciences
2000 Nature Genetics
2000 Nature Genetics
1997 PubMed
1995 Biochemical Pharmacology
1978 Science
1977 Science

Peers

Countries citing papers authored by John N. Weinstein

Since Specialization

Citations

This map shows the geographic impact of John N. Weinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N. Weinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N. Weinstein more than expected).

Fields of papers citing papers by John N. Weinstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John N. Weinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N. Weinstein. The network helps show where John N. Weinstein may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John N. Weinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John N. Weinstein Line = papers co-authored together John N. Weinstein links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SoS Notebook: an interactive multi-language data analysis environment Bioinformatics ·Bo Peng, Gao Wang, Jun Ma, K. E. Bezoyan, Chris Wakefield, James Melott, Yulun Chiu, Di Du, John N. Weinstein	2018	7
2	NSD1 Inactivation and SETD2 Mutation Drive a Convergence toward Loss of Function of H3K36 Writers in Clear Cell Renal Cell Carcinomas Cancer Research ·Xiaoping Su, Jianping Zhang, Roger Mouawad, Éva Compérat, Morgan Rouprêt, Frédérick Allanic, Jérôme Parra, Iryna Klymchuk, Erika J. Thompson, Banumathy Gowrishankar, Jane Houldsworth, John N. Weinstein, Jörg Tost, Bradley M. Broom, David Khayat, Jean-Philippe Spano, Nizar M. Tannir, Gabriel G. Malouf	2017	38
3	A Galaxy Implementation of Next-Generation Clustered Heatmaps for Interactive Exploration of Molecular Profiling Data Cancer Research ·Bradley M. Broom, Michaël Ryan, Robert Brown, L. Sivayamini, 吴平安, David W. Kane, James Melott, Chris Wakefield, Tod D. Casasent, Rehan Akbani, John N. Weinstein	2017	26
4	Altered Expression and Splicing of ESRP1 in Malignant Melanoma Correlates with Epithelial–Mesenchymal Status and Tumor-Associated Immune Cytolytic Activity Cancer Immunology Research ·Jun Yao, Otávia L. Caballero, Ying Huang, Calvin Lin, Donata Rimoldi, Andreas Behren, Jonathan Cebon, Mien‐Chie Hung, John N. Weinstein, Robert L. Strausberg, Qi Zhao	2016	49
5	TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer Cancer Research ·Jun Li, Leng Han, Paul Roebuck, Lixia Diao, Lingxiang Liu, Yuan Yuan, John N. Weinstein, Han Liang	2015	407
6	Next-Generation Sequencing of Translocation Renal Cell Carcinoma Reveals Novel RNA Splicing Partners and Frequent Mutations of Chromatin-Remodeling Genes Clinical Cancer Research ·Gabriel G. Malouf, Xiaoping Su, Hui Yao, Jianjun Gao, Liangwen Xiong, Qiuming He, Éva Compérat, Jérôme Couturier, Vincent Molinié, Bernard Escudier, Philippe Camparo, O. D. Pritula, Erika J. Thompson, David Khayat, Christopher G. Wood, Willie Yu, Bin Tean Teh, John N. Weinstein, Nizar M. Tannir	2014	97
7	Squamous Cell Carcinoma of the Oral Tongue in Young Non-Smokers Is Genomically Similar to Tumors in Older Smokers Clinical Cancer Research ·Curtis R. Pickering, Jiexin Zhang, David M. Neskey, Mei Zhao, Samar A. Jasser, Jiping Wang, Alexandra M. Ward, C. Jillian Tsai, Marcus V. Ortega Alves, Jane H. Zhou, Jennifer Drummond, Adel K. El‐Naggar, Richard A. Gibbs, John N. Weinstein, David A. Wheeler, Jing Wang, Mitchell J. Frederick, Jeffrey N. Myers	2014	118
8	AMPKα Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer Cancer Research ·Yon Hui Kim, Han Liang, Xiuping Liu, Ju‐Seog Lee, Y. Choi, Jae‐Ho Cheong, Hoguen Kim, Min Li, Thomas J. Downey, Matthew D. Dyer, Yongming Sun, 貴由岡村, Ellen M. Beasley, Hyun Cheol Chung, Sung Hoon Noh, John N. Weinstein, Chang‐Gong Liu, Garth Powis	2012	79
9	Integrative Analysis of Proteomic Signatures, Mutations, and Drug Responsiveness in the NCI 60 Cancer Cell Line Set Molecular Cancer Therapeutics ·Eun Sung Park, Rosalia Rabinovsky, Mark Carey, Bryan T. Hennessy, Roshan Agarwal, Wenbin Liu, Zhenlin Ju, Wanleng Deng, Yiling Lu, Hyun Goo Woo, Sang-Bae Kim, Jae‐Ho Cheong, Levi A. Garraway, John N. Weinstein, Gordon B. Mills, Ju‐Seog Lee, Michael A. Davies	2010	71
10	Exon Array Analyses across the NCI-60 Reveal Potential Regulation of TOP1 by Transcription Pausing at Guanosine Quartets in the First Intron Cancer Research ·William C. Reinhold, Jean‐Louis Mergny, Hongfang Liu, Michaël Ryan, Thomas D. Pfister, Robert J. Kinders, Ralph E. Parchment, James H. Doroshow, John N. Weinstein, Yves Pommier	2010	60
11	Genome-wide Analysis of Novel Splice Variants Induced by Topoisomerase I Poisoning Shows Preferential Occurrence in Genes Encoding Splicing Factors Cancer Research ·Stéphanie Solier, Jennifer J. Barb, Barry R. Zeebèrg, Sudhir Varma, Mike Baumgartner, Kurt W. Kohn, John N. Weinstein, Peter J. Munson, Yves Pommier	2010	46
12	Evaluation of current methods used to analyze the expression profiles of ATP-binding cassette transporters yields an improved drug-discovery database Molecular Cancer Therapeutics ·Josiah N. Orina, Anna Maria Calcagno, Chung‐Pu Wu, Sudhir Varma, Joanna H. Shih, Min Lin, Gabriel S. Eichler, John N. Weinstein, Yves Pommier, Suresh V. Ambudkar, Michael M. Gottesman, Jean-Pierre Gillet	2009	31
13	In vitro differential sensitivity of melanomas to phenothiazines is based on the presence of codon 600 BRAF mutation Molecular Cancer Therapeutics ·Ogechi Ikediobi, Mark Reimers, Steffen Durinck, Paul E. Blower, P. Andrew Futreal, Michael R. Stratton, John N. Weinstein	2008	11
14	Integrating Global Gene Expression and Radiation Survival Parameters across the 60 Cell Lines of the National Cancer Institute Anticancer Drug Screen Cancer Research ·Sally A. Amundson, T. Khanh, Lisa C. Vinikoor, 衣川恵, Christine A. Koch-Paiz, Jae-Yong Ahn, Mark Reimers, Yidong Chen, Dominic A. Scudiero, John N. Weinstein, Jeffrey M. Trent, Michael Bittner, Paul S. Meltzer, Albert J. Fornace	2008	207
15	Asparagine synthetase is a predictive biomarker of l -asparaginase activity in ovarian cancer cell lines Molecular Cancer Therapeutics ·Philip L. Lorenzi, John Diaz Antillanca, Michele Gunsior, Laurent Ozbun, William C. Reinhold, Sudhir Varma, Lijing Yan, Shaun Alexander, Amy Hutchinson, Elise C. Kohn, Paul K. Goldsmith, Michael J. Birrer, John N. Weinstein	2008	81
16	Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters Molecular Cancer Therapeutics ·Mitsunori Okabe, Gergely Szakács, Mark A. Reimers, Toshihiro Suzuki, Matthew D. Hall, Takaaki Abe, John N. Weinstein, Michael M. Gottesman	2008	124
17	Nonclassic Functions of Human Topoisomerase I: Genome-Wide and Pharmacologic Analyses Cancer Research ·Ze-Hong Miao, Audrey Player, Uma Shankavaram, 堀内史朗, Drazen B. Zimonjic, Philip L. Lorenzi, Xinliang Wu, Hong Liu, Tsutomu Shimura, 홍서애, 임주혜, Yongwei Zhang, Ernest S. Kawasaki, Nicholas C. Popescu, Mirit I. Aladjem, D. Goldstein, John N. Weinstein, Yves Pommier	2007	79
18	Chk2 Molecular Interaction Map and Rationale for Chk2 Inhibitors Clinical Cancer Research ·Yves Pommier, John N. Weinstein, Mirit I. Aladjem, Kurt W. Kohn	2006	69
19	The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress Cancer Research ·Frank Staib, Ana I. Robles, Lyuba Varticovski, Xin Wei Wang, Barry R. Zeebèrg, Nilcéa Amabília Rossi Gonçalves, Victor B. Zhurkin, Lorne J. Hofseth, S. Perwez Hussain, John N. Weinstein, Peter R. Galle, Curtis C. Harris	2005	87
20	Membrane Transporters and Channels Cancer Research ·Ying Huang, Pascale Anderle, Kimberly J. Bussey, Cátálin Bárbácioru, Uma Shankavaram, Zunyan Dai, William C. Reinhold, Audrey C. Papp, John N. Weinstein, Wolfgang Sadée	2004	231

About John N. Weinstein

John N. Weinstein is a scholar working on Molecular Biology, Virology, Cancer Research, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 322 papers that have together received 34.9k indexed citations. Recurring topics across this work include Gene expression and cancer classification (44 papers), Monoclonal and Polyclonal Antibodies Research (39 papers), Bioinformatics and Genomic Networks (33 papers), Computational Drug Discovery Methods (30 papers), HIV/AIDS drug development and treatment (24 papers), Lipid Membrane Structure and Behavior (24 papers), Epigenetics and DNA Methylation (21 papers) and RNA modifications and cancer (20 papers). The work is most often cited by research in Cancer Research (7.1k citations), Molecular Biology (22.9k citations), Oncology (6.9k citations), Biomaterials (2.0k citations) and Radiology, Nuclear Medicine and Imaging (3.1k citations). John N. Weinstein has collaborated with scholars based in United States, France and Poland. Frequent co-authors include Joseph A. Ludwig, Gordon B. Mills, Kenna Shaw, Joshua M. Stuart, Kyle Ellrott, Chris Sander, Ilya Shmulevich, Brad Ozenberger, Robert Blumenthal and William C. Reinhold. Their work appears in journals such as Molecular Cancer Therapeutics, Cancer Research, Science, Bioinformatics and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact